DSIP 5mg
US$ 25.07
low glutathione levels in parkinson's disease NAD IV Therapy and IV for Frontiers | Metabolic Parkinson's disease
Description
F., Fernandes, P
Cappetta D, De Angelis A, Sapio L, Prezioso L, Illiano M, Quaini F, et al
In patient-derived fibroblasts, both maximal mitochondrial respiration and mitochondrial ATP production rates were diminished, while the glycolytic fraction remained unaffected
The resulting acetylated proteins were then resolved and analyzed by SDS-PAGE and immunoblot
